NASDAQ: ERAS - Erasca, Inc.

Yield per half year: +47.03%
Sector: Healthcare

Erasca, Inc.

Underestimation
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 48.77 -100% -7.53 -100%
P/S 0 33.76 -100%
P/BV 1.03 4.82 -78.65%
P/FCF -3.68 60.98 -106.04%
Ev/Ebitda -2.1 -22.12 -90.53%
Ev/S 0 22.56 -100%
Ev/FCF -2.8 68.75 -104.08%
E/P -0.3298 0.0178 -1955.55%
Efficiency
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
0 4.83 -100% 0 0%
ROE -39.48 9.61 -511.03%
ROA -31.63 0.3359 -9517.06%
ROIC -86.37 7.63 -1231.33%
ROS 0 -25.17 -100%
ROCE -44.69 15.33 -391.49%
Debt
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.4054 -3.67 -88.94% -0.4537 -10.65%
Nеt Debt/Ebitda 0.2701 -3.44 -107.85%
Debt/Ratio 0.1413 0.1972 -28.32%
Debt/Equity 2.25 1.65 36.8%
Debt/Net Income -0.4467 10.31 -104.33%
Dividends
Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.5491 -100% 0 0%
Number of years of dividend growth 0 0.0789 -100%
DSI 0 0.2043 -100%
Average dividend growth 0 0.0591 -100%
Average percentage for 5 years 0 0.4924 -100%
Average percentage for payments 0 43.56 -100%
Difference from average difference in sector -0.5491
Growth impulse
Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue 5 years
0/10
0 -56.89 -100%
Growth impulse Ebitda 5 years 959.95 -64.81 -1581.18%
Growth impulse Net Income 5 years 942.02 -58.33 -1714.98%
Growth impulse FCF 5 years 836.29 -47 -1879.34%
Growth impulse EPS 5 years 362.55 -32.41 -1218.64%
IP Score
4.17/10

Similar companies

Amgen

Alexion

ABIOMED

Gilead Sciences